These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 11362777

  • 21. FDA approves Biaxin for MAC prophylaxis. Food and Drug Administration.
    J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):43. PubMed ID: 11363096
    [Abstract] [Full Text] [Related]

  • 22. Hold the big MAC.
    Young A.
    Notes Undergr; 1996 Apr; (no 32):6. PubMed ID: 11363450
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. HIV: prevention of opportunistic infections.
    Ioannidis J, Wilkinson D.
    Clin Evid; 2005 Jun; (13):834-53. PubMed ID: 16135281
    [No Abstract] [Full Text] [Related]

  • 26. Cidofovir recommended for approval for CMV retinitis.
    James JS.
    AIDS Treat News; 1996 Apr 05; (no 244):6-7. PubMed ID: 11363308
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Protease inhibitors linked to drop in CMV retinitis.
    AIDS Alert; 1997 Aug 05; 12(8):92-4. PubMed ID: 11364475
    [Abstract] [Full Text] [Related]

  • 29. Implants for CMV retinitis.
    Posit Aware; 1995 Aug 05; ():5. PubMed ID: 11362666
    [Abstract] [Full Text] [Related]

  • 30. CMV trial enrolling.
    Vazquez E.
    Posit Aware; 1997 Aug 05; 8(4):13. PubMed ID: 11364480
    [Abstract] [Full Text] [Related]

  • 31. Oral ganciclovir approved.
    AIDS Treat News; 1995 Jan 06; (No 214):1. PubMed ID: 11362183
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Treatment review.
    Treat Rev; 1995 Jan 06; (no 16):5. PubMed ID: 11362290
    [Abstract] [Full Text] [Related]

  • 34. Improved ganciclovir regimens.
    Cadman J.
    GMHC Treat Issues; 1995 Jan 06; 12(1):28-9. PubMed ID: 11364986
    [Abstract] [Full Text] [Related]

  • 35. Ganciclovir implants (Vitrasert).
    Treat Rev; 1996 Apr 06; (no 21):10. PubMed ID: 11363393
    [Abstract] [Full Text] [Related]

  • 36. [Oral ganciclovir for the prevention of illnesses caused by CMV].
    Vianna G.
    Sidahora; 1995 Apr 06; ():33-4. PubMed ID: 11362479
    [Abstract] [Full Text] [Related]

  • 37. AIDS patients have a new weapon against MAC infection.
    RN; 1994 Mar 06; 57(3):72. PubMed ID: 8128150
    [No Abstract] [Full Text] [Related]

  • 38. [Treatment and prevention of HIV infection and related opportunistic infections].
    Lumio J.
    Duodecim; 1992 Mar 06; 108(5):507-15. PubMed ID: 1366054
    [No Abstract] [Full Text] [Related]

  • 39. Ganciclovir approved to prevent CMV.
    Gilden D.
    GMHC Treat Issues; 1995 Nov 06; 9(11):3. PubMed ID: 11362989
    [Abstract] [Full Text] [Related]

  • 40. Opportunistic infections: stemming the tide.
    MacDougall DS.
    J Int Assoc Physicians AIDS Care; 1997 Apr 06; 3(4):42-7. PubMed ID: 11364202
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.